SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-17-148078
Filing Date
2017-04-28
Accepted
2017-04-28 16:02:55
Documents
4
Effectiveness Date
2017-04-28

Document Format Files

Seq Description Document Type Size
1 DEFA14A d359501ddefa14a.htm DEFA14A 34867
2 GRAPHIC g359501img1.jpg GRAPHIC 2820
3 GRAPHIC g359501img2.jpg GRAPHIC 3008
4 GRAPHIC g359501img3jpg.jpg GRAPHIC 3034
  Complete submission text file 0001193125-17-148078.txt   48510
Mailing Address 400 EAST JAMIE COURT, SUITE 101 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT, SUITE 101 SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Filer) CIK: 0001629137 (see all company filings)

IRS No.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37539 | Film No.: 17795335
SIC: 2834 Pharmaceutical Preparations